Kangstem Biotech, CMO consignment company receives phase 2 clinical IND approval 'CDMO, Ministry of Food and Drug Safety demonstrates clinical capabilities'
In: Contify Life Science News, 2024-03-05, S. 2
Zeitungsartikel
Zugriff:
Titel: |
Kangstem Biotech, CMO consignment company receives phase 2 clinical IND approval 'CDMO, Ministry of Food and Drug Safety demonstrates clinical capabilities'
|
---|---|
Link: | |
Zeitschrift: | Contify Life Science News, 2024-03-05, S. 2 |
Veröffentlichung: | 2024 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|